Tian Cheng Zhou, MD

Education and Work: Montefiore Medical Center, Bronx, NY General Surgery Internship July 2013-June 2014 Montefiore Medical Center, Bronx, NY Urologic Surgery Residency July 2014-June 2019 Albert Einstein College of Medicine, Bronx, NY Doctor of Medicine August 2009-June 2013 Northwestern University, Evanston, IL Bachelor of Science, Materials Science and Engineering September 2005-May 2009 • Magna cum […]

Read More

In NYC Subway, CyberKnife Prostate Cancer Ads Mislead

Survey Respondents Influenced by Claims Direct-to-consumer (DTC) advertising about the radiotherapy (RT) known as CyberKnife (CK), which is currently omnipresent in the New York City transit system, creates “inaccurate impressions” about the treatment’s “comparative effectiveness and safety” in prostate cancer, according to new research. That conclusion was made by investigators from Columbia University Medical Center […]

Read More

Health Insurers Now Cover Prostate Tests

A new law quietly went to effect last month that requires health insurers to cover the cost of routine prostate cancer screening. The new law places prostate-specific antigen screenings on the same level as mammograms. The intent is to encourage more men to take the test, which helps determine prostate cancer risk. New York is […]

Read More

Ilan J. Safir, MD, FACS

MEDICAL TRAINING: July 2017 – June 2018 Men’s Health-Andrology Fellowship Hofstra Northwell School of Medicine July 2013 – June 2017 Urology Residency Emory University School of Medicine July 2012 – June 2013 General Surgery Internship Emory University School of Medicine EDUCATION: 2008 – 2012 Doctor of Medicine University of California, Los Angeles School of Medicine […]

Read More

Prostate Cancer Screening recommendations get rolled back by US Task Force

The Us Preventive Services Task Force, an independent panel of experts that makes recommendations to the American public about preventive services updated their previous prostates cancer screening guidelines published in 2012. In 2012, they recommended against routine screening due to the risks involved in additional testing and treatment. Their new position recommends that men between […]

Read More